Papaverine

BreastfeedingPediatric
  • TRADE NAMES: Angioverin; Genabid; Optenyl; Pameion; Papaverine 60; Papaverini; Pavabid; Pavagen; Pavased; Pavatine
  • INDICATIONS: Peripheral and cerebral ischemia
  • CLASS: Opium alkaloid, Vasodilator, peripheral
  • HALF-LIFE: 0.5–2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Levodopa, Reboxetine

PREGNANCY CATEGORY: C

Our database has 16 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
NAILS
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
GENITOURINARY
LOCAL
OTHER


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top